Arcadia Biosciences, Inc.
RKDA Nasdaq
SEC CIK 1469443
Follow Arcadia Biosciences
Weekly email: filings, results
Revenue, last quarter
$1.6M
+24.3% vs same quarter last year
Net income
$1.8M
+105% vs same quarter last year
EPS, diluted
$0.29
−53.2% vs same quarter last year
Operating cash flow
−$1.3M
−397.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $4.9M | −$2.3M |
| FY24 | $5M | −$7M |
| FY23 | $4.5M | −$14M |
| FY22 | $7.4M | −$15.4M |
| FY21 | $6.8M | −$14.7M |
| FY20 | $8M | −$4.7M |
| FY19 | $1.2M | −$28.8M |
| FY18 | $1.5M | −$13.5M |
| FY17 | $4M | −$15.7M |
| FY16 | $3.2M | −$19.6M |
| FY15 | $5.4M | −$18M |
| FY14 | $7M | −$18.3M |
| FY13 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 36.2% | −51.5% | −48.1% |
| FY24 | 41.3% | −72.3% | −139.5% |
| FY23 | 51.2% | −137% | −314% |
| FY22 | 17.8% | −188.8% | −207.3% |
| FY21 | −28.4% | −524% | −216.2% |
| FY20 | 35.3% | −159% | −57.9% |
| FY19 | - | −1657.9% | −2464.1% |
| FY18 | - | −1152.3% | −920.8% |
| FY17 | 93% | −355.6% | −390.1% |
| FY16 | 71.9% | −584.1% | −615.6% |
| FY15 | 83.5% | −287.5% | −331.7% |
| FY14 | 71.4% | −217% | −262.7% |
| FY13 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$4.7M |
| FY24 | −$9.6M |
| FY23 | −$15.3M |
| FY22 | −$14M |
| FY21 | −$26.9M |
| FY20 | −$32.6M |
| FY19 | −$18.7M |
| FY18 | −$13.9M |
| FY17 | −$14M |
| FY16 | −$17.3M |
| FY15 | −$15.3M |
| FY14 | −$14.9M |
| FY13 | - |
- Arcadia Biosciences
- Consumer median
Show the numbers
| Year | Arcadia Biosciences | Consumer median |
|---|---|---|
| FY25 | −48.1% | 1.1% |
| FY24 | −139.5% | 1.5% |
| FY23 | −314% | 2.1% |
| FY22 | −207.3% | 2.5% |
| FY21 | −216.2% | 2.5% |
| FY20 | −57.9% | 1.8% |
| FY19 | −2464.1% | 2.6% |
| FY18 | −920.8% | 3.8% |
| FY17 | −390.1% | 3.8% |
| FY16 | −615.6% | 4.3% |
| FY15 | −331.7% | 3.8% |
| FY14 | −262.7% | 3.6% |
| FY13 | - | 3.9% |